Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis

Table 1 Characteristics of the included studies

First author	Year	Study period	Country	Study design	Participant, n	Age range (yr)	Treatment period (d)	Ref.
Simons	2006	2004-2005	Australia	Randomized, double blind, placebo-controlled	44	30-75	70	[24]
Ooi	2010	-	Malaysia	Randomized, double blind, placebo-controlled	32	18 years of age or older	84	[21]
Jones	2012	-	Canada	Randomized, double blind, placebo-controlled	127	20-75	63	[19]
Fuentes	2013	-	Spain	Randomized, double blind, placebo-controlled	60	18-65	84	[15]
Sanchez	2014	-	Canada	Randomized, double blind, placebo-controlled	93	18-55	168	[23]
Childs	2014	2008-2009	United Kingdom	Randomized, double blind, placebo-controlled, factorial, cross-over	42	25-65	21	[13]
Rajkumar	2015	-	India	Randomized, single blind, placebo-controlled	45	20-25	45	[22]
Ahn	2015	2012-2014	South Korea	Randomized, double blind, placebo-controlled	92	-	84	[12]
Higashikawa	2016	2013	Japan	Randomized, double blind, placebo-controlled	41	20-70	84	[17]
Fuentes	2016	2010	Spain	Randomized, double blind, placebo-controlled	60	18-25	84	[16]
Kim	2017	-	South Korea	Randomized, double blind, placebo-controlled	66	-	84	[20]
Costabile	2017	2015	United Kingdom	Randomized, double blind, placebo-controlled	46	18-50	84	[14]
Inoue	2018	-	Japan	Randomized, double blind, placebo-controlled	38	66-78	84	[18]